Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Pageot

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|December 19, 2013
Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern FranceEstelle Masseret, Sandra Banack, Farid Boumédiène, et al.
Molecular Neurobiology|March 1, 2017
Liver X Receptor Genes Variants Modulate ALS PhenotypeKevin Mouzat, Nicolas Molinari, Jovana Kantar, et al.
Frontiers in Neuroscience|May 16, 2020
Clinical Phenotype and Inheritance in Patients With C9ORF72 Hexanucleotide Repeat Expansion: Results From a Large French CohortFlorence Esselin, Kevin Mouzat, Anne Polge, et al.
Annals of Clinical and Translational Neurology|February 15, 2020
Rhythm disturbances as a potential early marker of Parkinson's disease in idiopathic REM sleep behavior disorderValérie Cochen De Cock, Delphine de Verbizier, Marie Christine Picot, et al.
Ebiomedicine|July 12, 2020
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trialWilliam Camu, Marius Mickunas, Jean-Luc Veyrune, et al.
Brain Communications|August 19, 2021
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2Ilaria Giovannelli, Nadhim Bayatti, Abigail Brown, et al.
BMJ Open|September 3, 2014
Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programmeAurélie Delzor, Philippe Couratier, Farid Boumédiène, et al.
Human Mutation|August 17, 2016
Mini-Exome Coupled to Read-Depth Based Copy Number Variation Analysis in Patients with Inherited AtaxiasCecilia Marelli, Claire Guissart, Cecile Hubsch, et al.
Lancet (London, England)|May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trialGilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|December 19, 2013
Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern FranceEstelle Masseret, Sandra Banack, Farid Boumédiène, et al.
Molecular Neurobiology|March 1, 2017
Liver X Receptor Genes Variants Modulate ALS PhenotypeKevin Mouzat, Nicolas Molinari, Jovana Kantar, et al.
Frontiers in Neuroscience|May 16, 2020
Clinical Phenotype and Inheritance in Patients With C9ORF72 Hexanucleotide Repeat Expansion: Results From a Large French CohortFlorence Esselin, Kevin Mouzat, Anne Polge, et al.
Annals of Clinical and Translational Neurology|February 15, 2020
Rhythm disturbances as a potential early marker of Parkinson's disease in idiopathic REM sleep behavior disorderValérie Cochen De Cock, Delphine de Verbizier, Marie Christine Picot, et al.
Ebiomedicine|July 12, 2020
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trialWilliam Camu, Marius Mickunas, Jean-Luc Veyrune, et al.
Brain Communications|August 19, 2021
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2Ilaria Giovannelli, Nadhim Bayatti, Abigail Brown, et al.
BMJ Open|September 3, 2014
Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programmeAurélie Delzor, Philippe Couratier, Farid Boumédiène, et al.
Human Mutation|August 17, 2016
Mini-Exome Coupled to Read-Depth Based Copy Number Variation Analysis in Patients with Inherited AtaxiasCecilia Marelli, Claire Guissart, Cecile Hubsch, et al.
Lancet (London, England)|May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trialGilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Pageof 2